| scholarly article | Q13442814 |
| P50 | author | Luciano De Petrocellis | Q60895642 |
| Katarzyna Starowicz-Bubak | Q28672038 | ||
| Vincenzo Di Marzo | Q29642556 | ||
| Maurizio Bifulco | Q39378638 | ||
| P2093 | author name string | Chiara Laezza | |
| Alessia Ligresti | |||
| Aniello Schiano Moriello | |||
| Giuseppe Portella | |||
| Simona Pisanti | |||
| Isabel Matias | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabidiol | Q422917 |
| breast carcinoma | Q18555947 | ||
| cannabinoids | Q422936 | ||
| P304 | page(s) | 1375-87 | |
| P577 | publication date | 2006-09-01 | |
| P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| P1476 | title | Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma | |
| P478 | volume | 318 |
| Q45067497 | A Metabolomic Approach Applied to a Liquid Chromatography Coupled to High-Resolution Tandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): Towards the Comprehensive Evaluation of the Chemical Composition of Cannabis Medicinal Extracts. |
| Q46772992 | A role for p53 in the regulation of lysosomal permeability by delta 9-tetrahydrocannabinol in rat cortical neurones: implications for neurodegeneration |
| Q33470761 | An Atmospheric Pressure Ionization MS/MS Assay using Online Extraction for the Analysis of 11 Cannabinoids and Metabolites in Human Plasma and Urine |
| Q39431492 | An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol |
| Q34074335 | Anandamide inhibits breast tumor-induced angiogenesis |
| Q35875977 | Anterior mediastinal mass in a young marijuana smoker: a rare case of small-cell lung cancer |
| Q90305460 | Anti-tumour actions of cannabinoids |
| Q26750399 | Anticancer mechanisms of cannabinoids |
| Q42254334 | Antioncogenic effects of transient receptor potential vanilloid 1 in the progression of transitional urothelial cancer of human bladder |
| Q39594134 | Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells |
| Q92862471 | Antitumor Cannabinoid Chemotypes: Structural Insights |
| Q38806270 | Antitumorigenic targets of cannabinoids - current status and implications |
| Q27005619 | Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review |
| Q34459813 | Association between cannabis use and the risk of bladder cancer: results from the California Men's Health Study |
| Q37046302 | Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer |
| Q34676610 | Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation? |
| Q90218263 | Breast cancer pathogenesis is linked to the intra-tumoral estrogen sulfotransferase (hSULT1E1) expressions regulated by cellular redox dependent Nrf-2/NFκβ interplay |
| Q41320922 | Can You Pass the Acid Test? Critical Review and Novel Therapeutic Perspectives of Δ9-Tetrahydrocannabinolic Acid A. |
| Q28075499 | Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence |
| Q34637516 | Cannabidiol as potential anticancer drug |
| Q37192723 | Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death |
| Q38347321 | Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis |
| Q37178591 | Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines |
| Q90703164 | Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia |
| Q33590580 | Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival |
| Q38012845 | Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? |
| Q42964808 | Cannabidiol induces intracellular calcium elevation and cytotoxicity in oligodendrocytes |
| Q36419293 | Cannabidiol inhibits angiogenesis by multiple mechanisms |
| Q33959167 | Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy |
| Q36120780 | Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells |
| Q39881941 | Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels. |
| Q59798485 | Cannabidiol's Upregulation of -acyl Ethanolamines in the Central Nervous System Requires -acyl Phosphatidyl Ethanolamine-Specific Phospholipase D |
| Q43289886 | Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis |
| Q24645241 | Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice |
| Q83997591 | Cannabidiol-induced apoptosis in murine microglial cells through lipid raft |
| Q34948216 | Cannabidiol: a promising drug for neurodegenerative disorders? |
| Q37285921 | Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action |
| Q33564023 | Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration |
| Q61448131 | Cannabinoid Ligands Targeting TRP Channels |
| Q64257876 | Cannabinoid Profiling of Hemp Seed Oil by Liquid Chromatography Coupled to High-Resolution Mass Spectrometry |
| Q36036102 | Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation |
| Q36832642 | Cannabinoid receptor 2 suppresses leukocyte inflammatory migration by modulating the JNK/c-Jun/Alox5 pathway |
| Q37546194 | Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies? |
| Q34095006 | Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines |
| Q50021052 | Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis |
| Q42700473 | Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms |
| Q38692926 | Cannabinoids as Modulators of Cell Death: Clinical Applications and Future Directions. |
| Q26866298 | Cannabinoids as therapeutic agents in cancer: current status and future implications |
| Q39119286 | Cannabinoids decrease the th17 inflammatory autoimmune phenotype |
| Q89597089 | Cannabinoids in the Pathophysiology of Skin Inflammation |
| Q41687142 | Cannabinoids in the management of difficult to treat pain |
| Q34049715 | Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. |
| Q27694715 | Cannabinoids, endocannabinoids, and cancer |
| Q39623454 | Cannabinol and cannabidiol exert opposing effects on rat feeding patterns |
| Q58596177 | Cannabis Therapeutics and the Future of Neurology |
| Q37826693 | Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation |
| Q34420153 | Cannabis smoking and respiratory health: consideration of the literature. |
| Q37629032 | Cellular calcium dynamics in lactation and breast cancer: from physiology to pathology. |
| Q34635002 | Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer |
| Q47963305 | Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol |
| Q34441093 | Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid. |
| Q38503842 | Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …. |
| Q37164208 | Critical appraisal of the potential use of cannabinoids in cancer management |
| Q37445966 | Current status and challenges of cytokine pharmacology. |
| Q64254135 | DNA Damaging Effects, Oxidative Stress Responses and Cholinesterase Activity in Blood and Brain of Wistar Rats Exposed to Δ-Tetrahydrocannabinol |
| Q39674047 | Decrease of Plasminogen Activator Inhibitor-1 May Contribute to the Anti-Invasive Action of Cannabidiol on Human Lung Cancer Cells |
| Q48777231 | Designing microorganisms for heterologous biosynthesis of cannabinoids. |
| Q37424055 | Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death |
| Q92398621 | Dose-Dependent Cannabidiol-Induced Elevation of Intracellular Calcium and Apoptosis in Human Articular Chondrocytes |
| Q37054169 | Effects of Cannabis sativa extract on haloperidol-induced catalepsy and oxidative stress in the mice |
| Q34625932 | Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes |
| Q34353689 | Effects of marijuana smoking on the lung |
| Q38593139 | Endocannabinoids and Cancer. |
| Q37219086 | Epigenetic control of skin differentiation genes by phytocannabinoids. |
| Q45342027 | Evaluation of anti-invasion effect of cannabinoids on human hepatocarcinoma cells. |
| Q39178517 | Expression and functionality of TRPV1 receptor in human MCF-7 and canine CF.41 cells |
| Q34461976 | Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). |
| Q64080447 | Future Aspects for Cannabinoids in Breast Cancer Therapy |
| Q34600163 | Hypothesizing that marijuana smokers are at a significantly lower risk of carcinogenicity relative to tobacco-non-marijuana smokers: evidenced based on statistical reevaluation of current literature |
| Q38990460 | In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma |
| Q28258759 | Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice |
| Q51891120 | Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews. |
| Q28298445 | International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂ |
| Q62018200 | Irinotecan and Δ⁸-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers |
| Q46613967 | JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. |
| Q60917775 | L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer |
| Q34563482 | Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme |
| Q58102489 | Medical Use of Cannabinoids |
| Q35643909 | Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids |
| Q64259803 | Modulation of the Endocannabinoid System as a Potential Anticancer Strategy |
| Q35287890 | Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer. |
| Q39102188 | Molecular Pharmacology of Phytocannabinoids |
| Q36157649 | Molecular Targets of Cannabidiol in Neurological Disorders |
| Q35054642 | Molecular mechanisms involved in the antitumor activity of cannabinoids on gliomas: role for oxidative stress |
| Q37808097 | Monocyclic phenolic acids; hydroxy- and polyhydroxybenzoic acids: occurrence and recent bioactivity studies |
| Q33348081 | Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels |
| Q24622202 | Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms |
| Q34143222 | Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action |
| Q34298903 | O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms |
| Q57471863 | Oxidant stress induction and signalling in xenografted (human breast cancer-tissues) plus estradiol treated or N-ethyl-N-nitrosourea treated female rats via altered estrogen sulfotransferase (rSULT1E1) expressions and SOD1/catalase regulations |
| Q34139377 | Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis |
| Q55333056 | Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. |
| Q39021389 | Pharmacology of cannabinoids in the treatment of epilepsy |
| Q39030530 | Physiological intestinal oxygen modulates the Caco-2 cell model and increases sensitivity to the phytocannabinoid cannabidiol |
| Q38955546 | Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas. |
| Q56768080 | Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsiv |
| Q61809317 | Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer |
| Q36085919 | Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2 |
| Q28075903 | Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents |
| Q39138715 | Preparation and characterization of Δ(9)-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines |
| Q28542740 | Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration |
| Q38732473 | Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture |
| Q55439675 | Review of the neurological benefits of phytocannabinoids. |
| Q91694412 | Role of Chemosensory TRP Channels in Lung Cancer |
| Q38889500 | Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer |
| Q61810420 | Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells |
| Q90325053 | Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention |
| Q36876322 | Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression |
| Q55463377 | Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas--possible role of Cannabis inhalation. |
| Q64121652 | Striking lung cancer response to self-administration of cannabidiol: A case report and literature review |
| Q34763649 | Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastases |
| Q28834689 | Synthetic and Biological Studies of Sesquiterpene Polygodial: Activity of 9-Epipolygodial against Drug-Resistant Cancer Cells |
| Q34026054 | Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer |
| Q39260828 | TRP channels as novel targets for endogenous ligands: focus on endocannabinoids and nociceptive signalling. |
| Q39693316 | TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer |
| Q24606148 | Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects |
| Q57175954 | Targeting Mitochondrial Ion Channels to Fight Cancer |
| Q34402827 | Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer. |
| Q34669534 | The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids |
| Q33908169 | The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products |
| Q55415383 | The current state and future perspectives of cannabinoids in cancer biology. |
| Q35193299 | The endocannabinoid system and cancer: therapeutic implication |
| Q37393042 | The endocannabinoid system and sex steroid hormone-dependent cancers. |
| Q24648473 | The endocannabinoid system as an emerging target of pharmacotherapy |
| Q37930973 | The endocannabinoid system in prostate cancer |
| Q38469671 | The evolving role of the endocannabinoid system in gynaecological cancer |
| Q91756670 | The heterogeneity and complexity of Cannabis extracts as antitumor agents |
| Q64284375 | The onus of cannabinoids in interrupting the molecular odyssey of breast cancer: A critical perspective on UPR and beyond |
| Q62661239 | To flourish or perish: evolutionary TRiPs into the sensory biology of plant-herbivore interactions |
| Q84066889 | Towards the use of cannabinoids as antitumour agents |
| Q34779637 | Transient receptor potential vanilloid 1 expression and functionality in mcf-7 cells: a preliminary investigation. |
| Q55129102 | VDAC1 as Pharmacological Target in Cancer and Neurodegeneration: Focus on Its Role in Apoptosis. |
| Q27686851 | What we know and do not know about the cannabinoid receptor 2 (CB2) |
| Q36198988 | Wittig derivatization of sesquiterpenoid polygodial leads to cytostatic agents with activity against drug resistant cancer cells and capable of pyrrolylation of primary amines |
Search more.